Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Kanda

Showing results (291-300 of 355) with videos related to

Pageof 36
Sort By:
Leukemia|June 16, 2012
Allogeneic hematopoietic stem cell transplantation for adult AML patients with granulocytic sarcomaH Shimizu, T Saitoh, M Tanaka, et al.
Mycoses|February 8, 2003
The value of the chest computed tomography halo sign in the diagnosis of invasive pulmonary aspergillosis. An autopsy-based retrospective study of 48 patientsM Kami, Y Kishi, T Hamaki, et al.
Cancer|October 3, 2000
Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trialsY Kanda, R Yamamoto, A Chizuka, et al.
Leukemia & Lymphoma|April 7, 2000
Pyogenic granuloma of the tongue early after allogeneic bone marrow transplantation for multiple myelomaY Kanda, C Arai, A Chizuka, et al.
Bone Marrow Transplantation|January 25, 2005
Value of surveillance blood culture for early diagnosis of occult bacteremia in patients on corticosteroid therapy following allogeneic hematopoietic stem cell transplantationA Chizuka, M Kami, Y Kanda, et al.
Bone Marrow Transplantation|November 10, 2009
Pharmacokinetics of CsA during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantationS Kimura, K Oshima, S Okuda, et al.
Leukemia & Lymphoma|August 23, 2000
Serum levels of soluble interleukin-2 receptor after bone marrow transplantation: a true marker of acute graft-versus-host diseaseM Kami, T Matsumura, Y Tanaka, et al.
Bone Marrow Transplantation|June 29, 2004
Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted in JapanM Yanada, N Emi, T Naoe, et al.
Bone Marrow Transplantation|April 6, 2004
Predictors for severe cardiac complications after hematopoietic stem cell transplantationM Sakata-Yanagimoto, Y Kanda, M Nakagawa, et al.
Leukemia|April 30, 2010
Prophylactic impact of imatinib administration after allogeneic stem cell transplantation on the incidence and severity of chronic graft versus host disease in patients with Philadelphia chromosome-positive leukemiaH Nakasone, Y Kanda, H Takasaki, et al.
Pageof 36

Showing results (291-300 of 355) with videos related to

Sort By:
Pageof 36
Leukemia|June 16, 2012
Allogeneic hematopoietic stem cell transplantation for adult AML patients with granulocytic sarcomaH Shimizu, T Saitoh, M Tanaka, et al.
Mycoses|February 8, 2003
The value of the chest computed tomography halo sign in the diagnosis of invasive pulmonary aspergillosis. An autopsy-based retrospective study of 48 patientsM Kami, Y Kishi, T Hamaki, et al.
Cancer|October 3, 2000
Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trialsY Kanda, R Yamamoto, A Chizuka, et al.
Leukemia & Lymphoma|April 7, 2000
Pyogenic granuloma of the tongue early after allogeneic bone marrow transplantation for multiple myelomaY Kanda, C Arai, A Chizuka, et al.
Bone Marrow Transplantation|January 25, 2005
Value of surveillance blood culture for early diagnosis of occult bacteremia in patients on corticosteroid therapy following allogeneic hematopoietic stem cell transplantationA Chizuka, M Kami, Y Kanda, et al.
Bone Marrow Transplantation|November 10, 2009
Pharmacokinetics of CsA during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantationS Kimura, K Oshima, S Okuda, et al.
Leukemia & Lymphoma|August 23, 2000
Serum levels of soluble interleukin-2 receptor after bone marrow transplantation: a true marker of acute graft-versus-host diseaseM Kami, T Matsumura, Y Tanaka, et al.
Bone Marrow Transplantation|June 29, 2004
Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted in JapanM Yanada, N Emi, T Naoe, et al.
Bone Marrow Transplantation|April 6, 2004
Predictors for severe cardiac complications after hematopoietic stem cell transplantationM Sakata-Yanagimoto, Y Kanda, M Nakagawa, et al.
Leukemia|April 30, 2010
Prophylactic impact of imatinib administration after allogeneic stem cell transplantation on the incidence and severity of chronic graft versus host disease in patients with Philadelphia chromosome-positive leukemiaH Nakasone, Y Kanda, H Takasaki, et al.
Pageof 36